Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count.
about
Age-dependent incidence, time course, and consequences of thymic renewal in adultsInterleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopeniaOral complications in hematopoietic stem cell recipients: the role of inflammationMechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer ImmunotherapyProgressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infectionDifferent profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy.Chimeric SCID-hu Model as a Human Hematopoietic Stem Cell Host That Recapitulates the Effects of HIV-1 on Bone Marrow Progenitors in Infected Patients.Interleukin-7 is decreased and maybe plays a pro-inflammatory function in primary immune thrombocytopenia.Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool.Increased bone marrow interleukin-7 (IL-7)/IL-7R levels but reduced IL-7 responsiveness in HIV-positive patients lacking CD4+ gain on antiviral therapyIL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells.Interleukin-7 compartmentalizes its receptor signaling complex to initiate CD4 T lymphocyte response.Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapy.IL-7 promotes CD95-induced apoptosis in B cells via the IFN-γ/STAT1 pathway.Redirecting the immune response: role of adoptive T cell therapy.IL-7 in human health and disease.Acute inducible ablation of GRP78 reveals its role in hematopoietic stem cell survival, lymphogenesis and regulation of stress signaling.The immunobiology of cord blood transplantationKinetics of IL-7 and IL-15 levels after allogeneic peripheral blood stem cell transplantation following nonmyeloablative conditioningThe impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancerIncreased circulating interleukin-7 levels in HIV-1-infected women.Impact of chemotherapy for HIV-1 related lymphoma on residual viremia and cellular HIV-1 DNA in patients on suppressive antiretroviral therapy.Occurrence of leukaemia following gene therapy of X-linked SCID.History and current status of newborn screening for severe combined immunodeficiency.Immune reconstitution following haematopoietic stem cell transplantation.IL-7 and SCF Levels Inversely Correlate with T Cell Reconstitution and Clinical Outcomes after Cord Blood Transplantation in Adults.Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naïve for HAART is related to reduced immune surveillance.New approaches for preventing and treating chronic graft-versus-host disease.Immune reconstitution following stem cell transplantation.Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartmentCytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation.Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter studyPrevention of graft-versus-host disease by anti IL-7Ralpha antibody.Do regulatory T cells play a role in the control of homeostatic proliferation?Homeostatic T cell proliferation as a barrier to T cell tolerance.T cell immune reconstitution following lymphodepletion.Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells.Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.
P2860
Q24519862-D792A801-F1B2-4E59-AEC2-D10BFDE3A200Q24798777-17220F41-3C5C-4FFA-9232-0FC254CC0620Q27027650-925F7A1A-BD75-44B9-B9B9-140A2FB2C535Q28084138-EFD8CAD9-ADED-40B0-8D67-65560AFE0740Q28732117-7BA51F23-EAD4-4581-B326-0507BE92B882Q33250098-FA481F53-33E2-4664-8401-ADCB63738637Q33382126-DFE391CA-5E06-4622-9AEE-94BDB09A2B88Q33414739-90598631-8E51-41BA-8439-51A79CBA2C95Q33553984-12B13D0E-3D37-4013-8744-E54F4B8AC69FQ33597681-8CFBDA85-7628-4AC9-BBC2-9EEB4FE60ACEQ33736534-C12EA494-115E-4131-BFA1-1E4621674CE1Q33786846-68ADAD42-A2C7-4CA3-B78B-C7DE27DB67E9Q33930706-199F5727-53C2-4599-BC4C-716BB2D69229Q34021307-44293CCD-9C4F-48B5-BA7C-D8064602715DQ34079831-3258E75C-A692-4740-8FCD-E897745EA484Q34110205-B4F43858-EBF7-43FA-BE48-7DB53C3E7BD4Q34123238-F1157625-9EB4-49FF-9A36-2E2FFEB62880Q34260682-FFDA8165-EEBA-4CF6-A85E-D02E478793A4Q34314109-276EA341-28A1-4E53-BFF2-A2685459FC3BQ34501067-2256EF69-EDB1-43AE-ACC8-EF3B0B9CE144Q34598248-4A0830FB-4615-4689-BB66-373AD6E182B1Q34646737-792FACC6-CF9A-4F48-9BEC-98DC696A9433Q35056752-184F2387-B184-45AA-96C0-FF59A10FABCCQ35123201-0FBEA76D-DC71-4C71-8BA0-BEA830B235EEQ35166805-8D60A891-ABF2-4CA9-8EA1-F0CCF826BD4EQ35613205-AA821BE4-69AC-415C-ADA6-78F5BCCF4913Q35675862-A7CE098D-0EA2-477C-98C6-9B48AF241D4BQ35692767-DEB7F08C-1084-4FD2-8836-EBCA84253F2BQ35830092-7DF4789A-34AD-4C83-A36D-D66F264C5CA6Q35847596-DFAB868A-A670-45B8-B809-34DCAC571154Q35883820-BB8842B0-A1CB-475C-B541-67083BE29887Q35895763-20FD9CD9-1C03-4A65-8BBF-52CCBF475343Q36006379-C2DDEB0F-9DB7-4B07-85EE-D1644DCA2B84Q36053935-4833B05B-E146-4A1F-8DB5-30E98577DB6DQ36059590-E97AF1B3-A9CD-4264-8517-70A8F96CF1CDQ36203576-670884B9-5786-416A-BCC8-757F62001324Q36251301-CCFF27CA-B336-40C5-B3E3-E5EBA4159B4FQ36334023-A1805937-6BA8-4FD3-86B9-9185518349E9Q36369770-FFDFA3B3-4C6E-41EF-B01D-EDEDFD45E04CQ36370817-AA8437E6-B608-4710-AC96-7D081E071D83
P2860
Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Serum levels of IL-7 in bone m ...... eristics and lymphocyte count.
@en
type
label
Serum levels of IL-7 in bone m ...... eristics and lymphocyte count.
@en
prefLabel
Serum levels of IL-7 in bone m ...... eristics and lymphocyte count.
@en
P2093
P356
P1476
Serum levels of IL-7 in bone m ...... eristics and lymphocyte count.
@en
P2093
P2888
P304
P356
10.1038/SJ.BMT.1701655
P407
P577
1999-04-01T00:00:00Z
P5875
P6179
1015946633